Interim Finance System Improvement Lead
About the role
Finance Systems Accountant (Sage Intacct)
- 12 month FTC
- Hybrid - 2 days a week in the office
- £65,000 - £70,000pa
An established UK charity is seeking an experienced Finance Systems Accountant to take ownership of the ongoing development, upgrades and optimisation of its Sage Intacct finance system.
This role will focus on post-implementation improvements, working closely with Finance, IT and external system partners to identify opportunities to enhance the system, improve processes, strengthen controls and maximise the functionality of Sage Intacct.
Key Responsibilities
- Lead and manage post-implementation upgrades and enhancements to Sage Intacct
- Identify opportunities to improve finance processes, system functionality and reporting
- Manage system changes from requirements gathering and design through to testing and implementation
- Lead UAT, testing, data validation and issue resolution
- Configure and enhance finance processes within Sage Intacct
- Review and improve GL, AP/AR, reporting, controls and finance workflows
- Work with external Sage Intacct partners and internal stakeholders to deliver system improvements
- Develop and maintain process documentation, system documentation and user guidance
- Support fin...
About this listing
This role passed our automated spam and quality filters and was active in our feed when last checked. Joboru is an aggregator — here is how we screen listings. If anything looks off, tell us.
Similar jobs you may like
Workforce Change & Restructuring Change Manager -VP
1 day agoAppcast
Deputy Care Manager
1 day agoFfordd Y Gyfraith, Bridgend
Dog Grooming Parlour assistant
1 day agoBrinsbury College
Branch Manager
1 day agoSCRIVENS LTD
DPC Programme Reporting Lead
1 day agoYorkshire Water
Associate Commodity Manager
1 day agoYunex Limited
Registered Manager / Registered Manager Designate
1 day agoHomecare Gurus Ltd.
Business Manager
1 day agoThe Solution Automotive Limited
Sr. Manager, Operational Strategy Lead
1 day agoPfizer